Founder & CEO, Module Innovations(MTI APAC 23) || Chevening CRISP Fellow || IIGP Top 10 Innovators of India 2017 ||
Antimicrobial Resistance (AMR) is a serious threat to global public health. The UK government has recently announced a new action plan to combat AMR, which includes support for industries to develop new treatments. I believe that a similar action plan is needed in India. AMR is a major problem in India, and it is essential that we take steps to address it. The Indian government should provide support to industries for the development of new treatments and diagnostics for AMR. This could include financial incentives, such as tax breaks or grants, as well as regulatory support, such as fast-tracking the approval process for new drugs/diagnostics. Organisations like Biotechnology Industry Research Assistance Council (BIRAC) are already doing it, but more is needed. The government and industries should also work to raise awareness of AMR among the public and healthcare professionals. This could be done through public health campaigns and educational programs. #publichealth #amr #policy Module Innovations
Today we have launched a new plan to tackle antimicrobial resistance (AMR). This national action plan commits the UK to: 🔵 reduce use of antimicrobials 🔵 strengthen surveillance of drug resistant infections before they emerge 🔵 incentivise industry to develop the next generation of treatments See our plan on Confronting Antimicrobial Resistance: https://lnkd.in/e9Xj6NxM #AMR #AntimicrobialResistance UK Research and Innovation, Department for Science, Innovation and Technology, UK Health Security Agency, Department for Environment, Food and Rural Affairs, Cabinet Office
